Literature DB >> 16947339

Focal nodular hyperplasia: lesion characteristics on state-of-the-art MRI including dynamic gadolinium-enhanced and superparamagnetic iron-oxide-uptake sequences in a prospective study.

Türkan Terkivatan1, Indra C van den Bos, Shahid M Hussain, Piotr A Wielopolski, Rob A de Man, Jan N M IJzermans.   

Abstract

PURPOSE: To image a cohort of patients with pathology-proven focal nodular hyperplasia (FNH) to assess which characteristics of state-of-the-art magnetic resonance imaging (MRI) of the liver are the most useful for improving the detection and characterization of FNH.
MATERIALS AND METHODS: In 14 patients, pathology-proven FNH (N=33) were prospectively examined using gadolinium (Gd) and superparamagnetic iron-oxide (SPIO) contrast media. All lesions were evaluated for signal intensity (SI), fatty infiltration, central scar, mode of enhancement with Gd, and uptake of SPIO. The percentage of dynamic contrast enhancement in the arterial, portal, and delayed phases was assessed. The contrast-to-noise ratio (CNR) before and after administration of SPIO contrast was calculated.
RESULTS: The SI of the lesions was low to isointense on T1-weighted (T1W) images, and intermediate to isointense on T2W images. Fatty infiltration of the lesions was present in 6%. The percentages of enhancement in the liver and lesion were 110%, 115%, and 95%, and 151%, 182%, and 160%, respectively (P<0.0001). All lesions showed uptake of SPIO with improved conspicuity of the central scar and septa. The CNR values precontrast and post-Gd/SPIO were significantly different for T1 in- and opposed-phase and black-blood echo-planar imaging (BBEPI).
CONCLUSION: Combining dynamic Gd-enhanced imaging with T1W and T2W sequences after administration of SPIO facilitates comprehensive evaluation of FNH. Copyright (c) 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16947339     DOI: 10.1002/jmri.20705

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  8 in total

1.  Hepatocellular adenoma: Should phenotypic classification direct management?

Authors:  Türkan Terkivatan; Jan N M Ijzermans
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2009-12       Impact factor: 46.802

Review 2.  Liver masses: a clinical, radiologic, and pathologic perspective.

Authors:  Sudhakar K Venkatesh; Vishal Chandan; Lewis R Roberts
Journal:  Clin Gastroenterol Hepatol       Date:  2013-09-18       Impact factor: 11.382

Review 3.  Contrast Agents for Hepatocellular Carcinoma Imaging: Value and Progression.

Authors:  Ying Zhang; Kazushi Numata; Yuewu Du; Shin Maeda
Journal:  Front Oncol       Date:  2022-06-02       Impact factor: 5.738

4.  Primary hepatic peripheral T-cell lymphoma: A case report.

Authors:  Hui-Juan Hu; Mei-Yan Liao; Yan-Juan Qu
Journal:  Oncol Lett       Date:  2014-05-07       Impact factor: 2.967

5.  Clinical and radiographic observations from four patients with primary hepatic lymphoma.

Authors:  Hui-Juan Hu; Yan-Juan Qu; Zhi-Xiong Tian; Zai-Peng Zhang
Journal:  Exp Ther Med       Date:  2015-12-16       Impact factor: 2.447

6.  Development of Focal Nodular Hyperplasia after Cyclophosphamide-Based Chemotherapy in a Patient with Breast Cancer.

Authors:  Dan-Qing Xue; Lan Yang
Journal:  Case Reports Hepatol       Date:  2018-10-22

7.  Diffusion weighted MR and apparent diffusion coefficient measurement in classification and characterization of noncystic focal liver lesions: does a clinical role exist?

Authors:  Francesco Mungai; Mario Morone; Alberta Villanacci; Maria Pia Bondioni; Lorenzo Nicola Mazzoni; Luigi Grazioli; Stefano Colagrande
Journal:  Medicine (Baltimore)       Date:  2014-07       Impact factor: 1.889

8.  Focal nodular hyperplasia of the liver.

Authors:  Stephen A Geller; Fernando P F de Campos
Journal:  Autops Case Rep       Date:  2014-03-30
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.